Feipeng Zhao

527 citations
29 papers · 377 indexed · h-index 10
Topics
Cancer-related molecular mechanisms research (7 papers)Advanced Battery Materials and Technologies (5 papers)MicroRNA in disease regulation (5 papers)
Partner nations
ChinaCanadaNew Zealand

In The Last Decade

Feipeng Zhao

26 papers receiving 376 citations

Peers

Feipeng Zhao
Comparison fields: 5 of 73
  • Molecular Biology 187
  • Cancer Research 151
  • Oncology 77
  • Immunology 54
  • Otorhinolaryngology 39
Replace Shan Chen with:
Shan Chen China
Ming‐Yi Lu Taiwan
Xiaobing Guan China
H.L. Chiou Taiwan
Zonggui Wang China
Dongdong Lin China
Ching‐Liang Meng Taiwan
Tiago Henrique Brazil
Santosh Kumar Behera India
Stefano Monteghirfo Italy
Feipeng Zhao relative to Shan Chen China Shan Chen's profile →
Citations per field
00.5×
Shan Chen · 1×
Citations per year

Countries citing papers authored by Feipeng Zhao

Since Specialization
Citations

This map shows the geographic impact of Feipeng Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feipeng Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feipeng Zhao more than expected).

Fields of papers citing papers by Feipeng Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feipeng Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feipeng Zhao. The network helps show where Feipeng Zhao may publish in the future.

Co-authorship network of co-authors of Feipeng Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Feipeng Zhao. A scholar is included among the top collaborators of Feipeng Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feipeng Zhao. Feipeng Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 0
4 3
5 0
6 1
7 1
8 5
9 1
10 4
11 2
12 12
13 6
14 25
15 16
16 8
17
Expression of FANCD2 is associated with prognosis in patients with nasopharyngeal carcinoma.
9
18 5
19 101
20 44

About Feipeng Zhao

Feipeng Zhao is a scholar working on Otorhinolaryngology, Cancer Research and Oncology, having authored 29 papers that have together received 377 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), Advanced Battery Materials and Technologies (5 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (151 citations), Otorhinolaryngology (39 citations) and Pharmacology (31 citations). Feipeng Zhao has collaborated with scholars based in China, Canada and New Zealand. Frequent co-authors include Juan Lü, Yan Yang, Xin Wu, Xu Zhang, Min Xu, Xiangping Li, Xiong Liu, Xiaohong Peng, Gang Li and Gang Qin. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Advanced Energy Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026